SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-041175
Filing Date
2012-07-26
Accepted
2012-07-26 17:07:25
Documents
5
Period of Report
2012-07-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v319617_8k.htm 8-K 26551
2 EXHIBIT 2.1 v319617_ex2-1.htm EX-2.1 402240
3 EXHIBIT 10.1 v319617_ex10-1.htm EX-10.1 16425
4 EXHIBIT 99.1 v319617_ex99-1.htm EX-99.1 24203
5 GRAPHIC logo.jpg GRAPHIC 16445
  Complete submission text file 0001144204-12-041175.txt   493370
Mailing Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021
Business Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021 516-482-1200
Neogenix Oncology Inc (Filer) CIK: 0001341293 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 8-K | Act: 34 | File No.: 000-53963 | Film No.: 12988077
SIC: 2835 In Vitro & In Vivo Diagnostic Substances